NL-OMON47197已完成2 期
Does arginine enhance galactose oxidative capacity in classic galactosemia? A pilot study - The effect of arginine on classic galactosemia
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Patient with classic galactosemia, homozygous for the p.Q188R mutation, diagnosed by GALT enzyme activity assay and GALT gene mutation analysis
- •- Eighteen years of age or older
- •- Capable of giving informed consent
排除标准
- •- Urea cycle disorders (assessed by post prandial amino acid profile in blood)
- •- Increased level of plasma uric acid
研究者
相似试验
已完成
2 期
The Effect of Arginine on Classic GalactosemiaClassic GalactosemiaNCT03580122Academisch Ziekenhuis Maastricht4
进行中（未招募）
1 期
Arginine as medication to improve outcome in patients with galactosemiaClassic galactosemiaEUCTR2014-002674-36-NL5
已完成
不适用
Residual galactose oxidation capacity and galactosylation abnormalities as possible predictors for galactose tolerance and outcome in patients with galactose-1-phosphate uridyltransferase deficiencyNL-OMON46279Academisch Medisch Centrum40
已完成
2 期
Effect of L-Arginine supplementation on antioxidant status in Pre-diabetic patients .pre-diabetic patient.Impaired glucose tolerancePrediabetesIRCT201211106415N2Vice chancellor for research,Tehran University of Medical Sciences46
已完成
2 期
arginine supplementation effect on CVDs.Obesity.Obesity, unspecifiedIRCT201501183236N6Shiraz University of Medical Sciences75